TREATMENT PATTERNS, CLINICAL OUTCOMES, AND BIOMARKER EVALUATION IN CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE OBSERVATIONAL STUDY IN US ONCOLOGY PRACTICES. (12th June 2019)